Prostate Cancer Clinical Trials in Nashville

Showing 241-260 of 359 trials

Visually Enhanced Education About Prostate Cancer

NCT02846870

This randomized clinical trial studies how well visually enhanced education works in improving prostate cancer and treatment knowledge in patients with prostate cancer that has not spread to other places in the body. Visually enhanced education includes pictures, drawings, and photos, may help doctors better convey information about radiation and prostate cancer to patients.

Stage I Prostate CancerStage II Prostate CancerStage III Prostate Cancer

Vanderbilt-Ingram Cancer Center30 participantsStarted Sep 2016

Nashville, Tennessee, United States

COMPLETEDPhase 1/2< 1 mile

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

NCT00002602

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells and may be an effective treatment for prostate cancer. PURPOSE: Phase I/II trial to study the effectiveness of radiation therapy in treating patients who have previously untreated stage II or stage III prostate cancer.

Prostate Cancer

Radiation Therapy Oncology Group1,084 participantsStarted May 1994

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Mobile, Alabama, United States +225 more locations

Visually Enhanced Education About Prostate Cancer

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Prostate Cancer Trials in Other Cities

A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors

Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer

Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T

Multi-Institutional Registry for Prostate Cancer Radiosurgery

Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate Cancer

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide

A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)

Prostate Cancer Intervention Versus Observation Trial (PIVOT)

ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer

Genetic Analysis of Hereditary Prostate Cancer

Analyses of Human Samples Collected in Clinical Trials

Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY

Safety, Tolerability, and PK of GT0918 (Proxalutamide) in Subjects With Metastatic Castrate Prostate Cancer

Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer

Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303)

Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer

A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer

Other Conditions in Nashville